Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53

Experimental Cell Research

Volumn 318, Issue 5, 2012, Pages 539-549

  Kang, Han Na ^a   Oh, Sang Cheul ^a   Kim, Jun Suk ^a   Yoo, Young A ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Colon cancer; Gli; MDM2; P53; Sonic hedgehog (Shh)

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BEVACIZUMAB; CYCLOHEXIMIDE; FLUOROURACIL; IRINOTECAN; MESSENGER RNA; OXALIPLATIN; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI3;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SENSITIZATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ERINACEIDAE;

EID: 84862813686     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.12.010     Document Type: Article

References (38)

1. McMahon A.P., Ingham P.W., Tabin C.J. Developmental roles and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 2003, 53:1-114.
2. Hooper J.E., Scott M.P. Communicating with hedgehogs. Nat. Rev. Mol. Cell Biol. 2005, 6:306-317.
3. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15:3059-3087.
4. Bale A.E., Yu K.P. The hedgehog pathway and basal cell carcinomas. Hum. Mol. Genet. 2001, 10:757-762.
5. Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., Isaacs J.T., Berman D.M., Beachy P.A. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004, 431:707-712.
6. Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004, 432:324-331.
7. Chen J.K., Taipale J., Cooper M.K., Beachy P.A. Inhibition of hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 2002, 16:2743-2748.
8. Chen J.K., Taipale J., Young K.E., Maiti T., Beachy P.A. Small molecule modulation of Smoothened activity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14071-14076.
9. Yoo Y.A., Kang M.H., Kim J.S., Oh S.C. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Carcinogenesis 2008, 29:480-490.
10. Berman D.M., Karhadkar S.S., Maitra A., Montes De Oca R., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N., Beachy P.A. Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846-851.
11. Xie K., Abbruzzese J.L. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 2003, 4:245-247.
12. Ma X., Chen K., Huang S., Zhang X., Adegboyega P.A., Evers B.M., Zhang H., Xie J. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005, 26:1698-1705.
13. Yoshikawa K., Shimada M., Miyamoto H., Higashijima J., Miyatani T., Nishioka M., Kurita N., Iwata T., Uehara H. Sonic hedgehog relates to colorectal carcinogenesis. J. Gastroenterol. 2009, 44:1113-1117.
14. Douard R., Moutereau S., Pernet P., Chimingqi M., Allory Y., Manivet P., Conti M., Vaubourdolle M., Cugnenc P.H., Loric S. Sonic hedgehog-dependent proliferation in a series of patients with colorectal cancer. Surgery 2006, 139:665-670.
15. Oniscu A., James R.M., Morris R.G., Bader S., Malcomson R.D., Harrison D.J. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia. J. Pathol. 2004, 203:909-917.
16. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
17. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237-1245.
18. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 1993, 362:857-860.
19. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
20. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997, 420:25-27.
21. Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M., Tanaka N. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:4838-4843.
22. Varnat F., Duquet A., Malerba M., Zbinden M., Mas C., Gervaz P., Ruiz i Altaba A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol. Med. 2009, 1:338-351.
23. Allen W.L., Coyle V.M., Jithesh P.V., Proutski I., Stevenson L., Fenning C., Longley D.B., Wilson R.H., Gordon M., Lenz H.J., Johnston P.G. Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin. Cancer Res. 2008, 14:6647-6655.
24. Allen W.L., Coyle V.M., Johnston P.G. Predicting the outcome of chemotherapy for colorectal cancer. Curr. Opin. Pharmacol. 2006, 6:332-336.
25. Mazumdar T., Devecchio J., Agyeman A., Shi T., Houghton J.A. Blocking hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Cancer Res. 2011, 71:5904-5914.
26. Mazumdar T., DeVecchio J., Shi T., Jones J., Agyeman A., Houghton J.A. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res. 2011, 71:1092-1102.
27. Shi T., Mazumdar T., Devecchio J., Duan Z.H., Agyeman A., Aziz M., Houghton J.A. cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells. PLoS One 2010, 5.
28. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:313-317.
29. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L., Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:851-856.
30. Sheng T., Li C., Zhang X., Chi S., He N., Chen K., McCormick F., Gatalica Z., Xie J. Activation of the hedgehog pathway in advanced prostate cancer. Mol. Cancer 2004, 3:29.
31. Qualtrough D., Buda A., Gaffield W., Williams A.C., Paraskeva C. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int. J. Cancer 2004, 110:831-837.
32. Nieuwenhuis E., Hui C.C. Hedgehog signaling and congenital malformations. Clin. Genet. 2005, 67:193-208.
33. Pasca di Magliano M., Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 2003, 3:903-911.
34. Levine A.J., Hu W., Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ. 2006, 13:1027-1036.
35. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
36. Malek R., Matta J., Taylor N., Perry M.E., Mendrysa S.M. The p53 inhibitor MDM2 facilitates Sonic hedgehog-mediated tumorigenesis and influences cerebellar foliation. PLoS One 2011, 6:e17884.
37. Stecca B., Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J. 2009, 28:663-676.
38. Lee Y., Kawagoe R., Sasai K., Li Y., Russell H.R., Curran T., McKinnon P.J. Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 2007, 26:6442-6447.